Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction

Background: The feasibility of spironolactone withdrawal in dilated cardiomyopathy patients with improved ejection fraction remains unknown. This study sought to determine whether spironolactone can be withdrawn safely in this circumstance. Methods: Consecutive patients with idiopathic dilated cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yanjia, Qiu, Zeping, Jiang, Jie, Su, Xiuxiu, Huang, Fanyi, Tang, Jing, Jin, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481596/
https://www.ncbi.nlm.nih.gov/pubmed/34604354
http://dx.doi.org/10.3389/fcvm.2021.725399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481596/
https://www.ncbi.nlm.nih.gov/pubmed/34604354
http://dx.doi.org/10.3389/fcvm.2021.725399

Ejemplares similares